Toxicogenomic Technologies and Risk Assessment of Environmental Carcinogens
|
 |
Download free pdf or purchase a hard copy here
|
| |
| Fifth meeting of the Committee on Emerging Issues and Data on Environmental Contaminants |
| December 15, 2003 |
| |
| 8:00 |
Welcome and Introduction |
|
David Eaton, University of Washington, and Linda Greer, NRDC |
|
Audio Clip |
| |
| 8:10 |
Role of non-tumor data in assessment of carcinogenicity |
|
James Bus, The Dow Chemical Company |
|
Download Presentation Slides | Audio Clip |
| |
| 10:35 |
Key issues (common critical gaps) in cancer determinations |
|
Jack Moore, Hollyhouse, Inc. |
|
Download Presentation Slides | Audio Clip |
| |
| 10:00 |
What types of toxicogenomics experiments have been attempted to address
critical gaps in risk assessment? |
|
Cheryl Walker, The University of Texas |
|
Download Presentation Slides | Audio Clip |
|
Kenneth Ramos, The University of Louisville |
|
Download Presentation Slides | Audio Clip |
| |
| 10:45 |
Case Study Discussion, Overview of method for case studies discussion |
| |
|
Case Study Discussion I: Presentation and Discussion of Butadiene Risk Assessment. |
|
Kenneth Ramos, The University of Louisville |
|
Download Presentation Slides | Audio Clip |
| |
| 12:30 |
Lunch |
| |
| |
| 1:30 |
Case Study Discussion II, Presentation and Discussion of Arsenic Risk Assessment |
| |
|
David Eaton, University of Washington, and Cheryl Walker, The University of Texas |
|
Download Presentation Slides | Audio Clip |
| |
| 3:35 |
Discussion & summary of issues presented in each of the two chemicals, with an aim of generalizing to list of opportunities for the field of toxicogenomics.
|
|
Linda Greer, NRDC |
|
Audio Clip |
| |
| |
| 5:15 |
Adjourn |
| |
|
NOTE: These are unedited audio files of the Fifth Meeting of the Committee on Emerging Issues and Data on Environmental Contaminants and is not an official report of National Academy of Sciences, National Academy of Engineering, Institute of Medicine, or National Research Council (collectively “National Academies”). Opinions and statements included in the recorded discussions are solely those of the individual persons or participants at the symposium, and are not necessarily adopted or endorsed or verified as accurate by the National Academies. |